TREVOR DAVIS: Open Payments
NPI 1629538822 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 25 payments from 14 companies in 2025. Trend: 2023 $945 · 2024 $621 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 5 | $91 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| PFIZER INC. | 3 | $51 |
| ABIOMED | 1 | $43 |
| SANOFI PASTEUR INC. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Seqirus USA Inc | 2 | $31 |
| Corcept Therapeutics | 1 | $20 |
| Soleno Therapeutics, Inc. | 1 | $18 |
| Organogenesis Inc. | 1 | $17 |
Products named: Dexcom G6 Transmitter, AIRSUPRA, Kerendia, BREZTRI, FLUZONE HIGH-DOSE, Korlym, VYKAT XR, TRUMENBA.
Industry payments across GA — which companies pay providers there.
